VC firm

Frazier Healthcare Partners

11 investors · 11 verified

Here are all investors at Frazier Healthcare Partners.

Investor preview

emails unlock with a plan

Investors on this list. Email addresses unlock with a plan.
namefirmemaillocationverified
Gordon EmpeyPartnerFrazier Healthcare PartnersUnited States3w ago
Elizabeth ParkPrincipalFrazier Healthcare PartnersUnited States3w ago
Joe CabralSenior AssociateFrazier Healthcare PartnersUnited States3w ago
John PaytonAnalystFrazier Healthcare PartnersUnited States3w ago
Daniel EstesGeneral PartnerFrazier Healthcare PartnersUnited States3w ago
Danica ElliottInvestorFrazier Healthcare PartnersUnited States3w ago
David TopperPartnerFrazier Healthcare PartnersUnited States3w ago
Patrick HeronManaging PartnerFrazier Healthcare PartnersUnited States3w ago
James N. TopperManaging PartnerFrazier Healthcare PartnersUnited States4w ago
Albert ChaManaging PartnerFrazier Healthcare PartnersUnited States4w ago
James W. BrushGeneral PartnerFrazier Healthcare PartnersUnited States4w ago

Browse all VCs

Recent investments at Frazier Healthcare Partners

  • Maze TherapeuticsPost Ipo Equity · $150M · 2026
  • Egetis TherapeuticsPost Ipo Equity · $38M · 2026
  • Sidewinder TherapeuticsSeries B · $140M · 2026
  • ImmutrinSeries A · $87M · 2026
  • Diagonal TherapeuticsSeries B · $130M · 2026
  • Iolyx TherapeuticsSeries B · $15M · 2025
  • TubulisSeries C · $400M · 2025
  • Attovia TherapeuticsSeries C · $90M · 2025
  • Hillstar BioSeries A · $67M · 2025
  • Callio TherapeuticsSeries A · $190M · 2025
  • Alesta TherapeuticsSeries A · $67M · 2025
  • Alpha-9 OncologySeries C · $180M · 2024

What founders say

4.1Based on 11 reviews